Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSH treatment in idiopathic oligoasthenospermia stratified by sperm DNA fragmentation
IRCT20101130005280N28Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of follicle-stimulating hormone in oligoasthenospermia (OA) and male infertility, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Spermogram, DNA fragmentation index and 2 more. Started Jul 2019; status: completed.
02
Drugs
follicle-stimulating hormone
03
Conditions
oligoasthenospermia (OA)male infertility
Beyond the preview
Go deeper on IRCT20101130005280N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101130005280N28.